Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients

Por Longbrake, EE, Ramsbottom, MJ, Cantoni, C, Ghezzi, L, Cross, AH, Piccio, L
Publicado no Mult Scler (2015)

Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial [Image: see text] [Image: see text]

Por Naismith, R.T., Piccio, L., Lyons, J.A., Lauber, J., Tutlam, N.T., Parks, B.J., Trinkaus, K., Song, S.K., Cross, A.H.
Publicado em 2010